Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells
Open Access
- 1 January 2011
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 19 (1), 83-92
- https://doi.org/10.1038/mt.2010.229
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Capsomer-Specific Fluorescent Labeling of Adenoviral Vector Particles Allows for Detailed Analysis of Intracellular Particle Trafficking and the Performance of Bioresponsive Bonds for Vector Capsid ModificationsHuman Gene Therapy, 2010
- An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human bloodGene Therapy, 2010
- Chemical Modification with High Molecular Weight Polyethylene Glycol Reduces Transduction of Hepatocytes and Increases Efficacy of Intravenously Delivered Oncolytic AdenovirusHuman Gene Therapy, 2009
- Clearance of Adenovirus by Kupffer Cells Is Mediated by Scavenger Receptors, Natural Antibodies, and ComplementJournal of Virology, 2008
- Substitution of Hexon Hypervariable Region 5 of Adenovirus Serotype 5 Abrogates Blood Factor Binding and Limits Gene Transfer to LiverMolecular Therapy, 2008
- Interaction of Systemically Delivered Adenovirus Vectors with Kupffer Cells in Mouse LiverHuman Gene Therapy, 2008
- Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivoProceedings of the National Academy of Sciences, 2008
- Pseudo-hydrodynamic Delivery of Helper-dependent Adenoviral Vectors into Non-human Primates for Liver-directed Gene TherapyMolecular Therapy, 2007
- Improved Hepatic Transduction, Reduced Systemic Vector Dissemination, and Long-Term Transgene Expression by Delivering Helper-Dependent Adenoviral Vectors into the Surgically Isolated Liver of Nonhuman PrimatesHuman Gene Therapy, 2006
- Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectorsBlood, 2003